Clinical usefulness of B-type natriuretic peptide in the diagnosis of pleural effusions due to heart failure

Respirology

Volumn 16, Issue 3, 2011, Pages 495-499

  Marinho, Felipe C A ^a   Vargas, Francisco S ^a   Fabri Jr , José ^a   Acencio, Milena M P ^a   Genofre, Eduardo H ^a   Antonangelo, Leila ^a   Sales, Roberta K B ^a   Teixeira, Lisete R ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

B type natriuretic peptide; Cardiac pleural effusion; False exudate; Heart failure; Transudate

Indexed keywords

NATRIURETIC PEPTIDE RECEPTOR B;

ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEART FAILURE; HUMAN; HYDROTHORAX; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PLEURA EFFUSION; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THORACOCENTESIS; TUBERCULOSIS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEART FAILURE; HUMANS; HYDROTHORAX; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NEOPLASMS; PARACENTESIS; PLEURAL EFFUSION; ROC CURVE; SENSITIVITY AND SPECIFICITY; STROKE VOLUME; TUBERCULOSIS, PULMONARY;

EID: 79953287036     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2011.01930.x     Document Type: Article

References (22)

1. Light RW, Macgregor MI, Luchsinger PC et al. Pleural effusions: the diagnostic separation of transudates and exudates. Ann. Intern.Med. 1972; 77: 507-13.
2. Porcel JM, Pena JM, Vicente de Vera C et al. Reappraisal of the standard method (Light's criteria) for identifying pleural exudates. Med. Clin. 2006; 126: 211-13.
3. Porcel JM, Martinez-Alonso M, Cao G et al. Biomarkers of heart failure in pleural fluid. Chest 2009; 136: 671-7.
4. Light RW. Use of pleural fluid N-terminal-pro-brain natriuretic peptide and brain natriuretic peptide in diagnosing pleural effusion due to congestive heart failure. Chest 2009; 136: 656-8.
5. Roth BJ, O'Meara TF, Cragun WH. The serum-effusion albumin gradient in the evaluation of pleural effusions. Chest 1990; 98: 546-9. (Pubitemid 20352679)
6. Kataoka H, Takada S. The role of thoracic ultrasonography for evaluation of patients with decompensated chronic heart failure. J. Am. Coll. Cardiol. 2000; 35: 1638-46.
7. Metintas M, Alatas O, Alatas F et al. Comparative analysis of biochemical parameters for differentiation of pleural exudates from transudates. Light's criteria, cholesterol, bilirubin, albumin gradient, alkaline phosphatase, creatine kinase, and uric acid. Clin. Chim. Acta 1997; 264: 149-62.
8. Burgess LJ, Maritz FJ, Taljaard JJ. Comparative analysis of the biochemical parameters used to distinguish between pleural transudates and exudates. Chest 1995; 107: 1604-9.
9. Gegenhuber A, Mueller T, Dieplinger B et al. Plasma B-type natriuretic peptide in patients with pleural effusions: preliminary observations. Chest 2005; 128: 1003-9. (Pubitemid 41140539)
10. Porcel JM, Chorda J, Cao G et al. Comparing serum and pleural fluid pro-brain natriuretic peptide (NT-proBNP) levels with pleural-to-serum albumin gradient for the identification of cardiac effusions misclassified by Light's criteria. Respirology 2007; 12: 654-9. (Pubitemid 47414870)
11. Romero-Candeira S, Fernandez C, Martin C et al. Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure. Am. J. Med. 2001; 110: 681-6.
12. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-43. (Pubitemid 13033817)
13. Maisel AS, Krishnaswamy P, Nowak RM et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N. Engl. J.Med. 2002; 347: 161-7.
14. Liao H, Na MJ, Dikensoy O et al. Diagnostic value of pleural fluid N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases. Respirology 2008; 13: 53-7.
15. Porcel JM, VivesM, Cao G et al.Measurement of pro-brain natriuretic peptide in pleural fluid for the diagnosis of pleural effusions due to heart failure. Am. J. Med. 2004; 116: 417-20.
16. Long AC, O'Neal HR, Peng S Jr et al. Comparison of pleural fluid N-terminal pro-brain natriuretic peptide and brain natriuretic-32 peptide levels. Chest 2010; 137: 1369-74.
17. Tomcsanyi J, Nagy E, Somloi M et al. NT-brain natriuretic peptide levels in pleural fluid distinguish between pleural transudates and exudates. Eur. J. Heart Fail. 2004; 6: 753-6.
18. Kolditz M,Halank M, Schiemanck CS et al.High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions. Eur. Respir. J. 2006; 28: 144-50.
19. Han CH, Choi JE, Chung JH. Clinical utility of pleural fluid NT-pro brain natriuretic peptide (NT-proBNP) in patients with pleural effusions. Intern.Med. 2008; 47: 1669-74.
20. Seyhan EC, Altin S, Cetinkaya E et al. The importance of pleural fluid and serum NT-proBNP levels in differentiating pleural effusion due to heart failure from other causes of effusion. Intern. Med. 2009; 48: 287-93.
21. Bossuyt PM, Reitsma JB, Bruns DE et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin. Chem. 2003; 49: 1-6.
22. Simel DL, Rennie D, Bossuyt PM. The STARD statement for reporting diagnostic accuracy studies: application to the history and physical examination. J. Gen. Intern.Med. 2008; 23: 768-74.